Teton Advisors, Inc. Exelixis, Inc. Transaction History

Teton Advisors, Inc.

$212 Million
Q3 2024

A detailed history of Teton Advisors, Inc. transactions in Exelixis, Inc. stock. As of the latest transaction made, Teton Advisors, Inc. holds 56,700 shares of EXEL stock, worth $1.89 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares

56,700

Previous 59,200 4.22%

Holding current value

$1.89 Million

Previous $1.33 Million 10.6%

% of portfolio

0.69%

Previous 0.59%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$21.96 - $27.6 $54,900 - $69,000	-2,500 Reduced 4.22%	56,700 $1.47 Million
Q1 2024 May 14, 2024	SELL	$20.17 - $23.93 $26,221 - $31,109	-1,300 Reduced 2.15%	59,200 $1.4 Million
Q4 2022 Feb 13, 2023	SELL	$14.96 - $17.39 $7,480 - $8,695	-500 Reduced 0.82%	60,500 $970,000
Q3 2022 Nov 10, 2022	SELL	$15.68 - $22.27 $15,680 - $22,270	-1,000 Reduced 1.61%	61,000 $956,000
Q2 2021 Aug 13, 2021	SELL	$17.95 - $25.56 $17,950 - $25,560	-1,000 Reduced 1.59%	62,000 $1.13 Million
Q1 2021 May 14, 2021	SELL	$20.53 - $25.22 $20,530 - $25,220	-1,000 Reduced 1.56%	63,000 $1.42 Million
Q3 2020 Nov 06, 2020	SELL	$20.67 - $26.94 $537,420 - $700,440	-26,000 Reduced 28.89%	64,000 $1.57 Million
Q2 2020 Aug 13, 2020	SELL	$16.46 - $27.42 $658,400 - $1.1 Million	-40,000 Reduced 30.77%	90,000 $2.14 Million
Q1 2020 May 14, 2020	SELL	$14.46 - $21.8 $433,800 - $654,000	-30,000 Reduced 18.75%	130,000 $2.24 Million
Q4 2019 Feb 14, 2020	SELL	$15.15 - $18.89 $227,250 - $283,350	-15,000 Reduced 8.57%	160,000 $2.82 Million
Q3 2018 Nov 02, 2018	SELL	$15.87 - $22.4 $79,350 - $112,000	-5,000 Reduced 2.78%	175,000 $3.1 Million
Q2 2018 Aug 10, 2018	SELL	$18.56 - $22.45 $185,600 - $224,500	-10,000 Reduced 5.26%	180,000 $3.87 Million
Q3 2017 Nov 01, 2017	BUY	$23.35 - $29.24 $4.44 Million - $5.56 Million	190,000	190,000 $4.6 Million

Others Institutions Holding EXEL

# of Institutions

502

Shares Held

243M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Teton Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Teton Advisors, Inc. with notifications on news.

Account

Teton Advisors, Inc. Exelixis, Inc. Transaction History